Shore Capital Reaffirms Buy Rating for ECO Animal Health Group (LON:EAH)

ECO Animal Health Group (LON:EAHGet Free Report)‘s stock had its “buy” rating reiterated by investment analysts at Shore Capital in a research note issued on Monday, MarketBeat reports. They currently have a GBX 150 ($2.01) target price on the stock. Shore Capital’s price target indicates a potential upside of 111.27% from the company’s previous close.

ECO Animal Health Group Stock Performance

Shares of EAH stock opened at GBX 71 ($0.95) on Monday. ECO Animal Health Group has a 12 month low of GBX 50 ($0.67) and a 12 month high of GBX 126 ($1.69). The company has a debt-to-equity ratio of 4.81, a current ratio of 2.96 and a quick ratio of 2.14. The firm has a market capitalization of £48.11 million, a P/E ratio of 45.90 and a beta of -0.05. The company’s fifty day moving average price is GBX 61.57 and its two-hundred day moving average price is GBX 60.65.

ECO Animal Health Group (LON:EAHGet Free Report) last issued its quarterly earnings data on Monday, July 14th. The company reported GBX 2.49 ($0.03) EPS for the quarter. ECO Animal Health Group had a net margin of 1.17% and a return on equity of 1.27%.

Insider Buying and Selling

In other news, insider David Hallas acquired 29,962 shares of the business’s stock in a transaction on Friday, April 25th. The shares were purchased at an average price of GBX 67 ($0.90) per share, for a total transaction of £20,074.54 ($26,877.15). 21.65% of the stock is owned by corporate insiders.

ECO Animal Health Group Company Profile

(Get Free Report)

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.

Further Reading

Receive News & Ratings for ECO Animal Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ECO Animal Health Group and related companies with MarketBeat.com's FREE daily email newsletter.